AAA
Affinity Asset Advisors’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.48M | Sell |
150,000
-150,000
| -50% | -$6.48M | 0.88% | 33 |
|
|
2025
Q1 | $10.4M | Buy |
300,000
+100,000
| +50% | +$3.46M | 0.99% | 21 |
|
|
2024
Q4 | $5.49M | Sell |
200,000
-100,000
| -33% | -$2.74M | 0.74% | 33 |
|
|
2024
Q3 | $7.64M | Buy |
300,000
+200,000
| +200% | +$5.09M | 1.04% | 29 |
|
|
2024
Q2 | $2.53M | Buy |
100,000
+50,000
| +100% | +$1.27M | 0.29% | 58 |
|
|
2024
Q1 | $1.55M | Sell |
50,000
-30,000
| -38% | -$928K | 0.19% | 63 |
|
|
2023
Q4 | $3.23M | Buy |
80,000
+50,000
| +167% | +$2.02M | 0.59% | 39 |
|
|
2023
Q3 | $791K | Sell |
30,000
-5,133
| -15% | -$135K | 0.22% | 56 |
|
|
2023
Q2 | $604K | Sell |
35,133
-284,867
| -89% | -$4.9M | 0.21% | 56 |
|
|
2023
Q1 | $5.31M | Buy |
+320,000
| New | +$5.31M | 1.75% | 17 |
|
|
2022
Q1 | – | Sell |
-494,046
| Closed | -$8.24M | – | 52 |
|
|
2021
Q4 | $8.24M | Sell |
494,046
-160,389
| -25% | -$2.68M | 2.99% | 9 |
|
|
2021
Q3 | $30.7M | Buy |
654,435
+104,435
| +19% | +$4.89M | 7.75% | 1 |
|
|
2021
Q2 | $33.5M | Sell |
550,000
-27,500
| -5% | -$1.68M | 12% | 1 |
|
|
2021
Q1 | $35.6M | Buy |
577,500
+422,500
| +273% | +$26M | 12.08% | 1 |
|
|
2020
Q4 | $11M | Buy |
+155,000
| New | +$11M | 5.84% | 3 |
|